The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy
Open accessAbstract
Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological treatment aimed at preventing the atherothrombotic complications in patients with a variety of coronary artery disease (CAD) manifestations. Prescribers of DAPT are confronted with a number of challenges that include selecting the appropriate P2Y12 inhibitor and determining the optimal duration of DAPT with the scope of minimizing the risk of ischemic and bleeding complications in light of each patient's clinical characteristic and circumstance. Recently, a guideline writing committee from the American College of Cardiology/American Heart Association (ACC/AHA) and a task force from the European Society of Cardiology (ESC) released their respective focused update recommendations on "Duration of DAPT in Patients with CAD" (ACC/AHA) and "DAPT in CAD" (ESC). This paper aims to review the ACC/AHA and ESC updates for DAPT to delineate common domains, consistent messages, and differences in recommended management strategies across the Atlantic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Self-citationRoffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Self-citationTicagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117 · cited 1×
“In the 2017 ESC update the topic is covered in greater detail, and 2 CORs are issued: 1 for the early upgrading from clopidogrel to ticagrelor in ACS (COR I, LOE B), as permitted in the PLATO (Platelet inhibition and patient outcomes) trial of ticagrelor (26); and 1 for switching between P2Y12 inhibitors if side-effec…”
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790 · cited 2×
“However, with the same LOE B (based on data from 2 large randomized trials) (12,13), in the 2017 ESC update, prasugrel or ticagrelor are given”
Method(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
Self-citationValgimigli, M., Bueno, H., Byrne, R. A., Collet, J.-P., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P., Mauri, L., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx419 · Cited by 2,987
Self-citationMehta, S. R., Yusuf, S., Peters, R. J., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., Malmberg, K., Rupprecht, H.-J., Zhao, F., Chrolavicius, S., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05701-4 · Cited by 2,809
Mehta, S. R., Yusuf, S., & Peters, R. J. G. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00559-7 · Cited by 2,578
Rivaroxaban with or without aspirin in stable cardiovascular disease
Eikelboom, J. W., Connolly, S. J., Bosch, J., Dagenais, G. R., Hart, R. G., Shestakovska, O., Diaz, R., Alings, M., Lonn, E. M., Anand, S. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709118 · Cited by 2,438
Long-term use of ticagrelor in patients with prior myocardial infarction
Bonaca, M. P., Bhatt, D. L., Cohen, M., Steg, P. G., Storey, R. F., Jensen, E. C., Magnani, G., Bansilal, S., Fish, M. P., Im, K., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500857 · Cited by 1,999
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Mauri, L., Kereiakes, D. J., Yeh, R. W., Driscoll-Shempp, P., Cutlip, D. E., Steg, P. G., Normand, S.-L. T., Braunwald, E., Wiviott, S. D., Cohen, D. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409312 · Cited by 1,928
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.018 · Cited by 1,772
Dewilde, W. J., Oirbans, T., Verheugt, F. W., Kelder, J. C., De Smet, B. J., Herrman, J.-P., Adriaenssens, T., Vrolix, M., Heestermans, A. A., Vis, M. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62177-1 · Cited by 1,719
Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.513 · Cited by 1,641
Self-citationPrevention of bleeding in patients with atrial fibrillation undergoing PCI
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., Birmingham, M., Ianus, J., Burton, P., van Eickels, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611594 · Cited by 1,590
Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation
Cannon, C. P., Bhatt, D. L., Oldgren, J., Lip, G. Y. H., Ellis, S. G., Kimura, T., Maeng, M., Merkely, B., Zeymer, U., Gropper, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708454 · Cited by 1,383
Price, M. J. (2011) · JAMA · doi:10.1001/jama.2011.290 · Cited by 1,308
Clopidogrel with or without Omeprazole in Coronary Artery Disease
Bhatt, D. L., Cryer, B. L., Contant, C. F., Cohen, M., Lanas, A., Schnitzer, T. J., Shook, T. L., Lapuerta, P., Goldsmith, M. A., Laine, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007964 · Cited by 1,240
Costa, F., van Klaveren, D., James, S., Heg, D., Räber, L., Feres, F., Pilgrim, T., Hong, M.-K., Kim, H.-S., Colombo, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30397-5 · Cited by 1,184
Self-citation2018 ESC/EACTS Guidelines on myocardial revascularization
Neumann, F. J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2018) · Kardiologia Polska · doi:10.5603/kp.2018.0228 · Cited by 1,126
Self-citationYeh, R. W., Secemsky, E. A., Kereiakes, D. J., Normand, S.-L. T., Gershlick, A. H., Cohen, D. J., Spertus, J. A., Steg, P. G., Cutlip, D. E., Rinaldi, M. J., et al. (2016) · JAMA · doi:10.1001/jama.2016.3775 · Cited by 934
Bedside monitoring to adjust antiplatelet therapy for coronary stenting
Collet, J.-P., Cuisset, T., Rangé, G., Cayla, G., Elhadad, S., Pouillot, C., Henry, P., Motreff, P., Carrié, D., Boueri, Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209979 · Cited by 887
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
Roe, M. T., Armstrong, P. W., Fox, K. A. A., White, H. D., Prabhakaran, D., Goodman, S. G., Cornel, J. H., Bhatt, D. L., Clemmensen, P., Martinez, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205512 · Cited by 874 · cited 2×
“Among these studies, TRILOGY ACS included only ACS patients with no invasive management, and they were not found to derive a significant ischemic benefit from prasugrel compared with clopidogrel (57).”
Method2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.009 · Cited by 820
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
Urban, P., Meredith, I. T., Abizaid, A., Pocock, S. J., Carrié, D., Naber, C., Lipiecki, J., Richardt, G., Iñiguez, A., Brunel, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503943 · Cited by 818
‘Ten Commandments’ for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization
Neumann, F.-J., & Sousa-Uva, M. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy658 · Cited by 805
Vranckx, P., Valgimigli, M., Jüni, P., Hamm, C., Steg, P. G., Heg, D., van Es, G. A., McFadden, E. P., Onuma, Y., van Meijeren, C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31858-0 · Cited by 791
Self-citationAmsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.016 · Cited by 777
Self-citationValgimigli, M., Campo, G., Monti, M., Vranckx, P., Percoco, G., Tumscitz, C., Castriota, F., Colombo, F., Tebaldi, M., Fucà, G., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.071589 · Cited by 672
Self-citationPretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
Montalescot, G., Bolognese, L., Dudek, D., Goldstein, P., Hamm, C., Tanguay, J.-F., ten Berg, J. M., Miller, D. L., Costigan, T. M., Goedicke, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1308075 · Cited by 657
A New Strategy for Discontinuation of Dual Antiplatelet Therapy
Kim, B.-K., Hong, M.-K., Shin, D.-H., Nam, C.-M., Kim, J.-S., Ko, Y.-G., Choi, D., Kang, T.-S., Park, B.-E., Kang, W.-C., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.043 · Cited by 646
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823a5596 · Cited by 632
Self-citationTrenk, D., Stone, G. W., Gawaz, M., Kastrati, A., Angiolillo, D. J., Müller, U., Richardt, G., Jakubowski, J. A., & Neumann, F.-J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.026 · Cited by 626
Self-citationSibbing, D., Aradi, D., Jacobshagen, C., Gross, L., Trenk, D., Geisler, T., Orban, M., Hadamitzky, M., Merkely, B., Kiss, R. G., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32155-4 · Cited by 615
Gwon, H.-C., Hahn, J.-Y., Park, K. W., Song, Y. B., Chae, I.-H., Lim, D.-S., Han, K.-R., Choi, J.-H., Choi, S.-H., Kang, H.-J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.059022 · Cited by 614
Feres, F. (2013) · JAMA · doi:10.1001/jama.2013.282183 · Cited by 589
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · Kardiologia Polska · doi:10.5603/kp.2018.0041 · Cited by 552
Self-citationEfficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
Giustino, G., Chieffo, A., Palmerini, T., Valgimigli, M., Feres, F., Abizaid, A., Costa, R. A., Hong, M.-K., Kim, B.-K., Jang, Y., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.760 · Cited by 454
Self-citationFiedler, K. A., Maeng, M., Mehilli, J., Schulz-Schüpke, S., Byrne, R. A., Sibbing, D., Hoppmann, P., Schneider, S., Fusaro, M., Ott, I., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.050 · Cited by 443
Schulz-Schupke, S., Byrne, R. A., ten Berg, J. M., Neumann, F.-J., Han, Y., Adriaenssens, T., Tolg, R., Seyfarth, M., Maeng, M., Zrenner, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu523 · Cited by 431
Self-citationColombo, A., Chieffo, A., Frasheri, A., Garbo, R., Masotti-Centol, M., Salvatella, N., Oteo Dominguez, J. F., Steffanon, L., Tarantini, G., Presbitero, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.008 · Cited by 430
Cuisset, T., Deharo, P., Quilici, J., Johnson, T. W., Deffarges, S., Bassez, C., Bonnet, G., Fourcade, L., Mouret, J. P., Lambert, M., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx175 · Cited by 414
International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies
Angiolillo, D. J., Rollini, F., Storey, R. F., Bhatt, D. L., James, S., Schneider, D. J., Sibbing, D., So, D. Y. F., Trenk, D., Alexopoulos, D., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.031164 · Cited by 397
Self-citationPalmerini, T., Benedetto, U., Bacchi-Reggiani, L., Riva, D. D., Biondi-Zoccai, G., Feres, F., Abizaid, A., Hong, M.-K., Kim, B.-K., Jang, Y., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60263-x · Cited by 396
Varenne, O., Cook, S., Sideris, G., Kedev, S., Cuisset, T., Carrié, D., Hovasse, T., Garot, P., El Mahmoud, R., Spaulding, C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32713-7 · Cited by 392
Cayla, G., Cuisset, T., Silvain, J., Leclercq, F., Manzo-Silberman, S., Saint-Etienne, C., Delarche, N., Bellemain-Appaix, A., Range, G., El Mahmoud, R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31323-x · Cited by 380
Hahn, J.-Y., Song, Y. B., Oh, J.-H., Cho, D.-K., Lee, J. B., Doh, J.-H., Kim, S.-H., Jeong, J.-O., Bae, J.-H., Kim, B.-O., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30493-8 · Cited by 372
Gilard, M., Barragan, P., Noryani, A. A. L., Noor, H. A., Majwal, T., Hovasse, T., Castellant, P., Schneeberger, M., Maillard, L., Bressolette, E., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.008 · Cited by 360
Novel antiplatelet agents in acute coronary syndrome
Franchi, F., & Angiolillo, D. J. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.156 · Cited by 353
Self-citationDuration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
Giustino, G., Baber, U., Sartori, S., Mehran, R., Mastoris, I., Kini, A. S., Sharma, S. K., Pocock, S. J., & Dangas, G. D. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.039 · Cited by 344
Navarese, E. P., Andreotti, F., Schulze, V., Ko odziejczak, M., Buffon, A., Brouwer, M., Costa, F., Kowalewski, M., Parati, G., Lip, G. Y. H., et al. (2015) · BMJ · doi:10.1136/bmj.h1618 · Cited by 330
Self-citationCollet, J.-P., Silvain, J., Barthélémy, O., Rangé, G., Cayla, G., Van Belle, E., Cuisset, T., Elhadad, S., Schiele, F., Lhoest, N., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60612-7 · Cited by 303
Lee, C. W., Ahn, J.-M., Park, D.-W., Kang, S.-J., Lee, S.-W., Kim, Y.-H., Park, S.-W., Han, S., Lee, S.-G., Seong, I.-W., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.003303 · Cited by 284
Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
Valgimigli, M., Patialiakas, A., Thury, A., McFadden, E., Colangelo, S., Campo, G., Tebaldi, M., Ungi, I., Tondi, S., Roffi, M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.053 · Cited by 280
Self-citationLip, G. Y. H., Collet, J.-P., Haude, M., Byrne, R., Chung, E. H., Fauchier, L., Halvorsen, S., Lau, D., Lopez-Cabanillas, N., Lettino, M., et al. (2019) · EP Europace · doi:10.1093/europace/euy174 · Cited by 274
Self-citationAngiolillo, D. J., Goodman, S. G., Bhatt, D. L., Eikelboom, J. W., Price, M. J., Moliterno, D. J., Cannon, C. P., Tanguay, J.-F., Granger, C. B., Mauri, L., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034722 · Cited by 238
Self-citationEvidence Review Committee Members, Bittl, J. A., Baber, U., Bradley, S. M., & Wijeysundera, D. N. (2016) · Circulation · doi:10.1161/cir.0000000000000405 · Cited by 227
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Capodanno, D., Mehran, R., Valgimigli, M., Baber, U., Windecker, S., Vranckx, P., Dangas, G., Rollini, F., Kimura, T., Collet, J.-P., et al. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0049-1 · Cited by 214
Self-citationMotovska, Z., Hlinomaz, O., Miklik, R., Hromadka, M., Varvarovsky, I., Dusek, J., Knot, J., Jarkovsky, J., Kala, P., Rokyta, R., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.024823 · Cited by 203
Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes
Notarangelo, F. M., Maglietta, G., Bevilacqua, P., Cereda, M., Merlini, P. A., Villani, G. Q., Moruzzi, P., Patrizi, G., Malagoli Tagliazucchi, G., Crocamo, A., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.029 · Cited by 196
Bittl, J. A., Baber, U., Bradley, S. M., & Wijeysundera, D. N. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.512 · Cited by 194
Capodanno, D., Patel, A., Dharmashankar, K., Ferreiro, J. L., Ueno, M., Kodali, M., Tomasello, S. D., Capranzano, P., Seecheran, N., Darlington, A., et al. (2011) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.110.960187 · Cited by 187
Self-citationSwitching P2Y12-receptor inhibitors in patients with coronary artery disease
Rollini, F., Franchi, F., & Angiolillo, D. J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.113 · Cited by 177
Self-citationHelft, G., Steg, P. G., Le Feuvre, C., Georges, J.-L., Carrie, D., Dreyfus, X., Furber, A., Leclercq, F., Eltchaninoff, H., Falquier, J.-F., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv481 · Cited by 177
Ariotti, S., Adamo, M., Costa, F., Patialiakas, A., Briguori, C., Thury, A., Colangelo, S., Campo, G., Tebaldi, M., Ungi, I., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.11.015 · Cited by 158
Self-citationAspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
Capodanno, D., & Angiolillo, D. J. (2016) · Circulation · doi:10.1161/circulationaha.116.023164 · Cited by 158
Self-citationVivas, D., Roldán, I., Ferrandis, R., Marín, F. R., Roldán, V., Tello‐Montoliu, A., Ruiz-Nodar, J. M., Gómez‐Doblas, J. J., Martín, A., Llau, J. V., et al. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.01.001 · Cited by 155
Han, Y., Xu, B., Xu, K., Guan, C., Jing, Q., Zheng, Q., Li, X., Zhao, X., Wang, H., Zhao, X., et al. (2016) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.115.003145 · Cited by 153
Hong, S., Shin, D., Kim, J., Kim, B., Ko, Y., Choi, D., Her, A., Kim, Y. H., Jang, Y., & Hong, M. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.04.036 · Cited by 139
Rossini, R., Tarantini, G., Musumeci, G., Masiero, G., Barbato, E., Calabrò, P., Capodanno, D., Leonardi, S., Lettino, M., Limbruno, U., et al. (2018) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.10.051 · Cited by 126
Self-citationAngiolillo, D. J. (2012) · Drugs · doi:10.2165/11640880-000000000-00000 · Cited by 125
Self-citationNakamura, M., Iijima, R., Ako, J., Shinke, T., Okada, H., Ito, Y., Andò, K., Anzai, H., Tanaka, H., Ueda, Y., et al. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.04.019 · Cited by 119
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary
Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.006 · Cited by 118
Self-citationAntithrombotic therapy for patients with STEMI undergoing primary PCI
Franchi, F., Rollini, F., & Angiolillo, D. J. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.18 · Cited by 115
Self-citationA Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?
Gargiulo, G., Windecker, S., Vranckx, P., Gibson, C. M., Mehran, R., & Valgimigli, M. (2016) · Circulation · doi:10.1161/circulationaha.116.023952 · Cited by 97
Self-citationIntracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial Investigators, Schulz, S., Angiolillo, D. J., Antoniucci, D., Bernlochner, I., Hamm, C. W., Jaitner, J., Laugwitz, K., Mayer, K., von Merzljak, B., et al. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9527-3 · Cited by 95
Self-citationAngiolillo, D. J., Goodman, S. G., Bhatt, D. L., Eikelboom, J. W., Price, M. J., Moliterno, D. J., Cannon, C. P., Tanguay, J., Granger, C. B., Mauri, L., et al. (2016) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.116.004395 · Cited by 94
Self-citationLópes, R. D., Vora, A. N., Liaw, D., Granger, C. B., Darius, H., Goodman, S. G., Mehran, R., Windecker, S., & Alexander, J. H. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.03.001 · Cited by 90
Berwanger, O. B., Nicolau, J. C., Carvalho, A. C., Jiang, L., Goodman, S. G., Nicholls, S. J., Parkhomenko, A. N., Валерьевич, А. О., Tajer, C. D., Málaga, G., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.0612 · Cited by 89
Vranckx, P., Lewalter, T., Valgimigli, M., Tijssen, J. G. P., Reimitz, P., Eckardt, L., Lanz, H., Zierhut, W., Smolnik, R., & Goette, A. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.10.009 · Cited by 86
Self-citationEvolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy
Moon, J. Y., Franchi, F., Rollini, F., & Angiolillo, D. J. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.12.004 · Cited by 81
Self-citationCapodanno, D., & Angiolillo, D. J. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.002301 · Cited by 71
Self-citationRole of genetic testing in patients undergoing percutaneous coronary intervention
Moon, J. Y., Franchi, F., Rollini, F., Rios, J. R. R., Kureti, M., Cavallari, L. H., & Angiolillo, D. J. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1353909 · Cited by 69
Self-citationJohnston, A., Jones, W. S., & Hernandez, A. F. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0749-2 · Cited by 62
Didier, R. J., Morice, M., Barragan, P. T., Noryani, A. A. L., Noor, H. A., Majwal, T., Hovasse, T., Castellant, P., Schneeberger, M., Maillard, L., et al. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.03.049 · Cited by 61
Lee, B. K., Kim, J., Lee, O.-H., Min, P., Yoon, Y.-W., Hong, B., Shin, D., Kang, T. S., Kim, B. O., Cho, D. K., et al. (2018) · EuroIntervention · doi:10.4244/eij-d-17-00792 · Cited by 57
Tailoring duration of DAPT with risk scores
Capodanno, D., & Angiolillo, D. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30591-3 · Cited by 54
Self-citationRoffi, M., Patrono, C., Collet, J., et al. (2016) · Cited by 46
Godiér, A., Fontana, P., Motte, S., Steib, A., Bonhomme, F., Schlumberger, S., Lecompte, T., Rosencher, N., Susen, S., Vincentelli, A., et al. (2018) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2017.12.004 · Cited by 35
The role of oral anticoagulant therapy in patients with acute coronary syndrome
Moon, J. Y., Nagaraju, D., Franchi, F., Rollini, F., & Angiolillo, D. J. (2017) · Therapeutic Advances in Hematology · doi:10.1177/2040620717733691 · Cited by 29
Self-citationMoon, J. Y., Franchi, F., Rollini, F., & Angiolillo, D. J. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2018.1400378 · Cited by 19
Self-citationSarafoff, N., Byrne, R. A., Mehilli, J., Sibbing, D., Kristensen, S. D., Laugwitz, K., Mæng, M., & Kastrati, A. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1312 · Cited by 13
Pharmacogenomic Testing to Select Antiplatelet Therapy
Price, M. J., & Angiolillo, D. J. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.021 · Cited by 11
Self-citationAlfonso, F., & Jiménez‐Borreguero, L. J. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx127 · Cited by 3
Self-citation
Cited by
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Mehran, R., Baber, U., Sharma, S. K., Cohen, D. J., Angiolillo, D. J., Briguori, C., Cha, J. Y., Collier, T., Dangas, G., Dudek, D., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908419 · Cited by 1,039
Self-citationAngiolillo, D. J., Bhatt, D. L., Cannon, C. P., Eikelboom, J. W., Gibson, C. M., Goodman, S. G., Granger, C. B., Holmes, D. R., Lopes, R. D., Mehran, R., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050438 · Cited by 302
Self-citationAntiplatelet therapy after percutaneous coronary intervention
Angiolillo, D. A., Galli, M., Collet, J.-P., Kastrati, A., & O'Donoghue, M. O. (2022) · EuroIntervention · doi:10.4244/eij-d-21-00904 · Cited by 299
Self-citationAngiolillo, D. J., Baber, U., Sartori, S., Briguori, C., Dangas, G., Cohen, D. J., Mehta, S. R., Gibson, C. M., Chandiramani, R., Huber, K., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.008 · Cited by 87
Self-citationACC/AHA/HRS Versus ESC Guidelines for the Diagnosis and Management of Syncope
Goldberger, Z. D., Petek, B. J., Brignole, M., Shen, W.-K., Sheldon, R. S., Solbiati, M., Deharo, J.-C., Moya, A., & Hamdan, M. H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.012 · Cited by 82
Metadata
- Authors
- Capodanno, D., Alfonso, F., Levine, G. N., Valgimigli, M., & Angiolillo, D. J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 72
- Issue
- 23
- Pages
- 2915-2931
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2902635828
- Cited by
- 366
- References
- 96
- FWCI
- 29.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.